Mabion S.A.
Mabion S.A., a biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland. It offers drug substance manufacturing, fill and finish, gene to vial end-to-end development, process development, analytics, and banking services. In addition, it offers cell line development… Read more
Mabion S.A. (MAB) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.081x
Based on the latest financial reports, Mabion S.A. (MAB) has a cash flow conversion efficiency ratio of -0.081x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-5.70 Million) by net assets (zł70.02 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Mabion S.A. - Cash Flow Conversion Efficiency Trend (2009–2024)
This chart illustrates how Mabion S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Mabion S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Mabion S.A. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Unlu Yatirim Holding AS
IS:UNLU
|
-0.041x |
|
Dawon Nexview Co., Ltd.
KQ:323350
|
0.018x |
|
Muliang Viagoo Technology Inc
PINK:MULG
|
-0.036x |
|
Thai Wah Public Company Limited
BK:TWPC
|
0.048x |
|
Centara Hotels & Resorts Leasehold Property Fund
BK:CTARAF
|
0.025x |
|
MicroCloud Hologram Inc.
NASDAQ:HOLO
|
0.004x |
|
Enad Global 7 AB (publ)
PINK:ENADF
|
0.015x |
|
Formosa Prosonic Industries
KLSE:9172
|
0.009x |
Annual Cash Flow Conversion Efficiency for Mabion S.A. (2009–2024)
The table below shows the annual cash flow conversion efficiency of Mabion S.A. from 2009 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | zł111.44 Million | zł39.86 Million | 0.358x | +1905.77% |
| 2023-12-31 | zł117.78 Million | zł-2.33 Million | -0.020x | -103.90% |
| 2022-12-31 | zł76.51 Million | zł38.84 Million | 0.508x | +182.24% |
| 2021-12-31 | zł53.31 Million | zł-32.91 Million | -0.617x | -235.56% |
| 2020-12-31 | zł-77.39 Million | zł-35.24 Million | 0.455x | -70.89% |
| 2019-12-31 | zł-21.58 Million | zł-33.76 Million | 1.564x | +269.28% |
| 2018-12-31 | zł42.14 Million | zł-38.94 Million | -0.924x | -192.46% |
| 2017-12-31 | zł-54.16 Million | zł-54.13 Million | 0.999x | +124.49% |
| 2016-12-31 | zł3.73 Million | zł-15.22 Million | -4.082x | -1433.70% |
| 2015-12-31 | zł127.64 Million | zł-33.97 Million | -0.266x | -988.98% |
| 2014-12-31 | zł997.84 Million | zł-24.39 Million | -0.024x | +53.89% |
| 2013-12-31 | zł520.55 Million | zł-27.59 Million | -0.053x | -615.46% |
| 2012-12-31 | zł1.82 Billion | zł-13.51 Million | -0.007x | +98.71% |
| 2011-12-31 | zł20.37 Million | zł-11.74 Million | -0.576x | -794.40% |
| 2010-12-31 | zł21.72 Million | zł-1.40 Million | -0.064x | -101.62% |
| 2009-12-31 | zł-74.80K | zł-298.41K | 3.990x | -- |